We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $324M
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
-1.14%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
AUM
$413M
AUM Growth
-$86.4M
Cap. Flow
-$84M
Cap. Flow %
-20.33%
Top 10 Hldgs %
38.04%
Holding
179
New
18
Increased
5
Reduced
5
Closed
38

Top Buys

Rank Stock Value
1
JOBS
51job Inc
JOBS
+$21.4M
2
JOYY
JOYY Inc
JOYY
+$9.76M
3
STMP
Stamps.com, Inc.
STMP
+$6.98M
4
FIVN icon
FIVE9
FIVN
+$5.97M
5
WBT
Welbilt, Inc.
WBT
+$5.86M

Sector Composition

Rank Sector Weight
1 Financials 25.08%
2 Industrials 14.12%
3 Technology 10.69%
4 Communication Services 9.56%
5 Materials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVIIW
126
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$401K 0.1%
41,237
JWSM.WS
127
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$393K 0.1%
40,249
CCVI.WS
128
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$332K 0.08%
33,999
COCHW icon
129
Envoy Medical Warrant
COCHW
$425K
$330K 0.08%
33,332
SPKB
130
DELISTED
Silver Spike Acquisition Corp II Class A Ordinary Shares
SPKB
$294K 0.07%
30,000
PICC.WS
131
DELISTED
Pivotal Investment Corporation III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
PICC.WS
$292K 0.07%
29,999
AEON.WS
132
DELISTED
AEON Biopharma Inc
AEON.WS
$290K 0.07%
29,768
FRXB.WS
133
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$275K 0.07%
28,199
CLIM.WS
134
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
$248K 0.06%
25,379
VOSOW
135
DELISTED
Virtuoso Acquisition Corp. Warrant
VOSOW
$248K 0.06%
25,000
TCVA
136
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$245K 0.06%
25,000
TSIBW
137
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$196K 0.05%
20,000
LCAAW
138
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$162K 0.04%
16,666
AAC.WS
139
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$156K 0.04%
15,999
FTAAW
140
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
$133K 0.03%
13,448
SDSTW
141
Stardust Power Inc Warrant
SDSTW
$4.93M
$129K 0.03%
13,333
DOYU
142
DouYu International Holdings
DOYU
$139M
-140,153
Closed -$9.59M
GWH icon
143
ESS Tech
GWH
$22M
-20,473
Closed -$3.04M
LIDR icon
144
AEye
LIDR
$52.8M
-2,547
Closed -$766K
NVTS icon
145
Navitas Semiconductor
NVTS
$2.84B
-197,399
Closed -$1.96M
OPAD icon
146
Offerpad Solutions
OPAD
$18.3M
-1,000
Closed -$1.49M
PAYO icon
147
Payoneer
PAYO
$2.42B
-50,000
Closed -$519K
PL icon
148
Planet Labs
PL
$7.3B
-61,618
Closed -$602K
RBOT
149
DELISTED
Vicarious Surgical
RBOT
-3,712
Closed -$1.11M
SPIR icon
150
Spire Global
SPIR
$444M
-34,704
Closed -$2.77M

Similar funds

Athos Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Athos Capital held 179 positions worth $413M, down 17% from $499M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Athos Capital withdrew a net $84M in Q3 2021, closing 38 positions and reducing 5 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $33.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, Athos Capital opened a new position in 51job Inc worth $20.2M.

  • Athos Capital's largest Q3 2021 buy was 51job Inc: 290,511 shares worth $20.2M.
  • Athos Capital added most to Welbilt, Inc. in Q3 2021, an estimated $5.86M increase.
  • Athos Capital's biggest Q3 2021 reduction was Xilinx Inc, cutting an estimated $12.3M.
  • Athos Capital fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $33.2M.
  • Athos Capital's ten largest holdings make up 38% of its $413M portfolio in Q3 2021.
  • Athos Capital opened 18 new positions and closed 38 in Q3 2021.
  • Athos Capital's portfolio value fell 17% quarter-over-quarter to $413M.

Based on Athos Capital's 13F filing for Q3 2021, filed 12 Nov 2021.